In Vitro Fertilization (IVF) Market Projected to Hit USD 44.68 Billion by 2035; Rising Infertility Rates Fueling 7.47% CAGR – SNS Insider

Advancements in assisted reproductive technologies, and increasing demand for personalized fertility treatments drive the global IVF market from a USD 21.74 billion valuation in 2025 to nearly double by 2035.

Austin, United States, April 01, 2026 (GLOBE NEWSWIRE) -- In Vitro Fertilization (IVF) Market Size & Growth Analysis:

As per SNS Insider, The In Vitro Fertilization (IVF) Market size was valued at USD 21.74 Billion in 2025 and is projected to reach USD 44.68 Billion by 2035, growing at a CAGR of 7.47% during 2026–2035. The market for in vitro fertilization (IVF) is expanding quickly due to the increasing prevalence of infertility, the high level of knowledge on IVF techniques, and advancements in the field of infertility therapies.

Get a Sample Report of In Vitro Fertilization (IVF) Market: https://www.snsinsider.com/sample-request/1053

The U.S. In Vitro Fertilization (IVF) Market has been valued at USD 7.6 Billion in 2025 and is expected to reach USD 15.2 Billion in 2035, growing at a CAGR of 7.21% from 2026 to 2035. Rising rates of infertility, improvements in reproductive technologies, heightened awareness, easier access to fertility treatments, supportive healthcare legislation, and an increasing need for individualized assisted reproductive solutions are all factors contributing to growth.

Rising Infertility Rates and Advancements in Assisted Reproductive Technologies to Augment Market Growth Globally

The major factor that is contributing to the growth of the IVF market is the rise in the number of infertile people due to the change in lifestyle. Technological advancements in IVF procedures such as intracytoplasmic sperm injection, preimplantation genetic testing, culture media, etc., are also contributing to the growth of the IVF market. In addition, awareness about ART procedures, and government initiatives, is also contributing to the growth of the IVF market.

Segmentation Analysis:

By Product

In 2025, Reagents & Media dominated with 45% share owing to their critical role in ensuring optimal embryo culture and high treatment success rates. Instruments segment is growing at a rapid pace due to technological advancements in IVF lab instruments.

By Cycle Type

In 2025, Fresh IVF Cycles dominated with 50% share due to their established clinical protocols, higher adoption rates, and proven success in assisted reproduction. Frozen IVF Cycles is growing rapidly owing to the growing trend in fertility preservation. 

By Application

In 2025, Female Infertility dominated with 60% share driven by higher prevalence of conditions such as polycystic ovary syndrome (PCOS), endometriosis, and age-related fertility decline. Male Infertility is the fastest-growing segment, supported by advancements in sperm retrieval techniques, assisted reproductive procedures, such as ICSI, and increasing awareness about male reproductive health.

By End-User

Fertility Clinics dominated with 55% share due to their specialization in assisted reproductive technologies, higher patient volume, and tailored treatment plans. Hospitals are the fastest-growing segment, as more healthcare centers integrate fertility services into their offerings.

Regional Insights:

With 35% of the worldwide IVF market, North America has a firm grip on the industry. Better health infrastructure, widespread adoption of ART methods, and well-established fertility clinics are the reasons behind North America's stronghold.

The IVF market is expanding at the quickest rate in Asia-Pacific. Rising rates of infertility, growing knowledge of assisted reproductive technologies, and growing healthcare infrastructure are the main drivers of rapid growth. Adoption is also being fueled by growing investments in fertility clinics, easier access to cutting-edge IVF techniques, and rising disposable incomes in nations, such as China, Japan, and India.

Need Any Customization Research on In Vitro Fertilization (IVF) Market, Enquire Now: https://www.snsinsider.com/enquiry/1053

Major In Vitro Fertilization (IVF) Companies Analysis Listed in the Report are

• Vitrolife AB
• Cook Medical
• Merck KGaA KGaA
• Thermo Fisher Scientific , Inc.
• CooperSurgical, Inc.
• Ferring Pharmaceuticals
• GC Biotech
• Genea Biomedx
• Origio (MediTech A/S)

• Irvine Scientific ( Becton Dickinson )
• Hamilton Thorne Ltd.
• SAGE IVF
• Esco Micro Pte Ltd.
• Lifecodexx GmbH
• Vitrolife AB
• Gynemed GmbH & Co. KG
• Zhejiang Hisun Pharmaceuticals
• Gynemed Laboratories
• CooperSurgical Fertility & Genomic Solutions
• KARL STORZ SE & Co. KG

In Vitro Fertilization (IVF) Market Segmentation

By Product

• Reagents & Media
• Instruments
• Accessories

By Cycle Type

• Fresh IVF Cycles
• Frozen IVF Cycles
• Donor Egg IVF Cycles

By Application

• Female Infertility
• Male Infertility
• Others

By End User

• Fertility Clinics
• Hospitals
• Surgical Centers

Recent Developments:

• In 2025, Vitrolife AB advanced IVF procedures by launching innovative embryo culture media and automated laboratory instruments, improving treatment success rates and workflow efficiency for fertility clinics globally.
• In 2025, Cook Medical contributed to the IVF market by introducing advanced instruments and devices for egg retrieval and embryo transfer, enhancing procedural precision and success rates for fertility clinics globally.

Exclusive Sections of the Report (The USPs):

• ADOPTION & DEPLOYMENT METRICS – helps you understand patient preference for IVF over alternative treatments, growth in IVF cycles (fresh vs. frozen), and expansion of fertility clinics and laboratory infrastructure globally.
• PRODUCT, TECHNOLOGY & TREATMENT TRENDS – helps you evaluate market share across reagents, instruments, and accessories, along with adoption of advanced technologies such as ICSI, PGT, and AI-assisted embryo selection.
• CLINICAL OUTCOMES & SUCCESS RATE METRICS – helps you assess improvements in IVF success rates driven by advanced lab technologies, media optimization, and personalized treatment protocols.
• DISTRIBUTION & SERVICE UTILIZATION METRICS – helps you analyze the share of IVF procedures across fertility clinics, hospitals, and surgical centers, along with cost implications for patients.
• REGIONAL EXPANSION & MARKET PENETRATION METRICS – helps you track geographic expansion of IVF providers and entry into new markets globally.
• PATIENT BEHAVIOR & TREATMENT PREFERENCE METRICS – helps you identify trends in fertility preservation, donor program adoption, patient satisfaction, and repeat treatment rates across regions.

Purchase Single User PDF of In Vitro Fertilization (IVF) Market Report (20% Discount): https://www.snsinsider.com/checkout/1053

In Vitro Fertilization (IVF) Market Report Scope

Browse More Reports

Infertility Treatment Market

Assisted Reproductive Technology (ART) Market

Genetic Testing Market

Women’s Health Diagnostics Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: info@snsinsider.com